Agape Atp CORP 10-Q quarterly reports

Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.

NASDAQ
Agape ATP Corporation reported a sharp decline in revenue and continued net losses for the second quarter of 2026, raising concerns about its financial stability.
NASDAQ
Agape ATP Corporation reported a decrease in revenue for the first quarter of 2026, primarily driven by a strategic shift away from its network marketing business.
NASDAQ
Agape ATP Corporation reported increased net losses for Q3 and the nine months ended September 30, 2025, despite revenue growth driven by new segments, while facing significant going concern doubts and internal control weaknesses.
NASDAQ
Agape ATP Corporation reported a wider net loss for the second quarter and first half of 2025, despite revenue growth driven by new green energy and skincare segments, as it grapples with declining gross margins and significant internal control weaknesses.
NASDAQ
Agape ATP Corporation's Q1 2025 revenue decreased by 9.3% year-over-year, driven by a strategic shift in focus and a decline in overseas customer revenue.
NASDAQ
Agape ATP Corporation's Q3 2024 results show a decrease in overall revenue, primarily due to a decline in network marketing, while experiencing growth in complementary health therapies.
NASDAQ
Agape ATP Corporation's Q2 2024 results show a shift in revenue streams with a decline in network marketing and growth in complementary health therapies, alongside increased operating expenses.
NASDAQ
Agape ATP Corporation's Q1 2024 results show a decrease in revenue and an increase in net loss compared to the same period last year, primarily due to a decline in network marketing business revenue.